Literature DB >> 9224439

Behavioral treatment of depression in dementia patients: a controlled clinical trial.

L Teri1, R G Logsdon, J Uomoto, S M McCurry.   

Abstract

The current study is a controlled clinical investigation of two nonpharmacological treatments of depression in patients with Alzheimer's disease. Two active behavioral treatments, one emphasizing patient pleasant events and one emphasizing caregiver problem solving, were compared to an equal-duration typical care condition and a wait list control. Seventy-two patient-caregiver dyads were randomly assigned to one of four conditions and assessed pre-, post-, and at 6-months follow-up. Patients in both behavioral treatment conditions showed significant improvement in depression symptoms and diagnosis as compared with the two other conditions. These gains were maintained at 6-month follow-up. Caregivers in each behavioral condition also showed significant improvement in their own depressive symptoms, while caregivers in the two other conditions did not. Results indicate that behavioral interventions for depression are important and effective strategies for treating demented patients and their caregivers.

Entities:  

Mesh:

Year:  1997        PMID: 9224439     DOI: 10.1093/geronb/52b.4.p159

Source DB:  PubMed          Journal:  J Gerontol B Psychol Sci Soc Sci        ISSN: 1079-5014            Impact factor:   4.077


  117 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Update on Alzheimer's disease: recent findings and treatments.

Authors:  R O'Hara; M S Mumenthaler; J A Yesavage
Journal:  West J Med       Date:  2000-02

3.  Treatment fidelity evidence for BE-ACTIV - a behavioral intervention for depression in nursing homes.

Authors:  Suzanne Meeks; Kimberly Van Haitsma; S Kelly Shryock
Journal:  Aging Ment Health       Date:  2018-12-06       Impact factor: 3.658

Review 4.  [Efficacy of caregiver support groups for dementia].

Authors:  A Kurz; J Hallauer; S Jansen; J Diehl
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

5.  Positivity and well-being among community-residing elders and nursing home residents: what is the optimal affect balance?

Authors:  Suzanne Meeks; Kimberly Van Haitsma; Irene Kostiwa; Stanley A Murrell
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-01-06       Impact factor: 4.077

6.  Behavioral disturbance in dementia.

Authors:  Abhilash K Desai; Lori Schwartz; George T Grossberg
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

7.  Depressive symptoms in Chinese-American subjects with cognitive impairment.

Authors:  Steven Z Chao; Brandy R Matthews; Jennifer S Yokoyama; Ngan Betty Lai; Hilary Ong; Marian Tse; Runfen Frances Yuan; Amy Lin; Joel Kramer; Kristine Yaffe; John Kornak; Bruce L Miller; Howard J Rosen
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-08       Impact factor: 4.105

8.  [Acute illness and depression in the elderly and the influence of cognitive impairment : AIDE-cog trial].

Authors:  J Hummel; C Weisbrod; L Bösch; K Himpler; G Böhm; S Diener; A Gaebel; L Dipper; T Zieschang; P Oster; D Kopf
Journal:  Z Gerontol Geriatr       Date:  2012-01-27       Impact factor: 1.281

9.  Benefits of mindfulness training for patients with progressive cognitive decline and their caregivers.

Authors:  Ken A Paller; Jessica D Creery; Susan M Florczak; Sandra Weintraub; M-Marsel Mesulam; Paul J Reber; Jessica Kiragu; Joshua Rooks; Adam Safron; Darby Morhardt; Mary O'Hara; Kathryn L Gigler; John M Molony; Michael Maslar
Journal:  Am J Alzheimers Dis Other Demen       Date:  2014-08-25       Impact factor: 2.035

10.  Testing Tele-Savvy: Protocol for a randomized controlled trial.

Authors:  Mariya A Kovaleva; Elizabeth Bilsborough; Patricia C Griffiths; Joe Nocera; Melinda Higgins; Fayron Epps; Katie Kilgore; Allison Lindauer; Darby Morhardt; Raj C Shah; Kenneth Hepburn
Journal:  Res Nurs Health       Date:  2018-02-05       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.